시장조사 보고서 : 세계의 시신경 척수염 약물 시장예측 2021년-2026년

■ 영문 제목 : Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02107 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 105 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 시신경 척수염 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (당질 코르티코이드, 면역 치료, 기타)와 용도별 시장규모 (급성 발작, 완화 예방 치료) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 시신경 척수염 약물 시장 점유율
- 지역별 시신경 척수염 약물 시장규모
- 주요지역의 종류별 시장규모 (당질 코르티코이드, 면역 치료, 기타)
- 주요지역의 용도별 시장규모 (급성 발작, 완화 예방 치료)
- 미주의 시신경 척수염 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 시신경 척수염 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 시신경 척수염 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 시신경 척수염 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 시신경 척수염 약물 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Pfizer, Fresenius, Teva, Sandoz, Intas, Gyjtrs, NANG KUANG, Tianjin Kingyork, Baxter, CSL, Grifols, Octapharma, CBOP
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Neuromyelitis Optica Drug will have significant change from previous year. By the most conservative estimates of global Neuromyelitis Optica Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 42 million in 2020. Over the next five years the Neuromyelitis Optica Drug market will register a 3.1% CAGR in terms of revenue, the global market size will reach US$ 47 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuromyelitis Optica Drug market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Glucocorticoids
Immunotherapies
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Acute Attack
Remission Prophylactic Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Fresenius
Teva
Sandoz
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromyelitis Optica Drug Market Size 2016-2026
2.1.2 Neuromyelitis Optica Drug Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Neuromyelitis Optica Drug Segment by Type
2.2.1 Glucocorticoids
2.2.2 Glucocorticoids
2.2.3 Others
2.3 Neuromyelitis Optica Drug Market Size by Type
2.3.1 Global Neuromyelitis Optica Drug Market Size CAGR by Type
2.3.2 Global Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021)
2.4 Neuromyelitis Optica Drug Segment by Application
2.4.1 Acute Attack
2.4.2 Remission Prophylactic Treatment
2.5 Neuromyelitis Optica Drug Market Size by Application
2.5.1 Global Neuromyelitis Optica Drug Market Size CAGR by Application
2.5.2 Global Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021)

3 Neuromyelitis Optica Drug Market Size by Players
3.1 Neuromyelitis Optica Drug Market Size Market Share by Players
3.1.1 Global Neuromyelitis Optica Drug Revenue by Players (2019-2021E)
3.1.2 Global Neuromyelitis Optica Drug Revenue Market Share by Players (2019-2021E)
3.2 Global Neuromyelitis Optica Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Neuromyelitis Optica Drug by Regions
4.1 Neuromyelitis Optica Drug Market Size by Regions (2016-2021)
4.2 Americas Neuromyelitis Optica Drug Market Size Growth (2016-2021)
4.3 APAC Neuromyelitis Optica Drug Market Size Growth (2016-2021)
4.4 Europe Neuromyelitis Optica Drug Market Size Growth (2016-2021)
4.5 Middle East & Africa Neuromyelitis Optica Drug Market Size Growth (2016-2021)

5 Americas
5.1 Americas Neuromyelitis Optica Drug Market Size by Country (2016-2021)
5.2 Americas Neuromyelitis Optica Drug Market Size by Type (2016-2021)
5.3 Americas Neuromyelitis Optica Drug Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Neuromyelitis Optica Drug Market Size by Region (2016-2021)
6.2 APAC Neuromyelitis Optica Drug Market Size by Type (2016-2021)
6.3 APAC Neuromyelitis Optica Drug Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Neuromyelitis Optica Drug by Country (2016-2021)
7.2 Europe Neuromyelitis Optica Drug Market Size by Type (2016-2021)
7.3 Europe Neuromyelitis Optica Drug Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Neuromyelitis Optica Drug by Region (2016-2021)
8.2 Middle East & Africa Neuromyelitis Optica Drug Market Size by Type (2016-2021)
8.3 Middle East & Africa Neuromyelitis Optica Drug Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Neuromyelitis Optica Drug Market Forecast
10.1 Global Neuromyelitis Optica Drug Forecast by Regions (2021-2026)
10.1.1 Global Neuromyelitis Optica Drug Forecast by Regions (2021-2026)
10.1.2 Americas Neuromyelitis Optica Drug Forecast
10.1.3 APAC Neuromyelitis Optica Drug Forecast
10.1.4 Europe Neuromyelitis Optica Drug Forecast
10.1.5 Middle East & Africa Neuromyelitis Optica Drug Forecast
10.2 Americas Neuromyelitis Optica Drug Forecast by Countries (2021-2026)
10.2.1 United States Neuromyelitis Optica Drug Market Forecast
10.2.2 Canada Neuromyelitis Optica Drug Market Forecast
10.2.3 Mexico Neuromyelitis Optica Drug Market Forecast
10.2.4 Brazil Neuromyelitis Optica Drug Market Forecast
10.3 APAC Neuromyelitis Optica Drug Forecast by Region (2021-2026)
10.3.1 China Neuromyelitis Optica Drug Market Forecast
10.3.2 Japan Neuromyelitis Optica Drug Market Forecast
10.3.3 Korea Neuromyelitis Optica Drug Market Forecast
10.3.4 Southeast Asia Neuromyelitis Optica Drug Market Forecast
10.3.5 India Neuromyelitis Optica Drug Market Forecast
10.3.6 Australia Neuromyelitis Optica Drug Market Forecast
10.4 Europe Neuromyelitis Optica Drug Forecast by Country (2021-2026)
10.4.1 Germany Neuromyelitis Optica Drug Market Forecast
10.4.2 France Neuromyelitis Optica Drug Market Forecast
10.4.3 UK Neuromyelitis Optica Drug Market Forecast
10.4.4 Italy Neuromyelitis Optica Drug Market Forecast
10.4.5 Russia Neuromyelitis Optica Drug Market Forecast
10.5 Middle East & Africa Neuromyelitis Optica Drug Forecast by Region (2021-2026)
10.5.1 Egypt Neuromyelitis Optica Drug Market Forecast
10.5.2 South Africa Neuromyelitis Optica Drug Market Forecast
10.5.3 Israel Neuromyelitis Optica Drug Market Forecast
10.5.4 Turkey Neuromyelitis Optica Drug Market Forecast
10.5.5 GCC Countries Neuromyelitis Optica Drug Market Forecast
10.6 Global Neuromyelitis Optica Drug Forecast by Type (2021-2026)
10.7 Global Neuromyelitis Optica Drug Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Neuromyelitis Optica Drug Product Offered
11.1.3 Pfizer Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Fresenius
11.2.1 Fresenius Company Information
11.2.2 Fresenius Neuromyelitis Optica Drug Product Offered
11.2.3 Fresenius Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Fresenius Main Business Overview
11.2.5 Fresenius Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Neuromyelitis Optica Drug Product Offered
11.3.3 Teva Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Sandoz
11.4.1 Sandoz Company Information
11.4.2 Sandoz Neuromyelitis Optica Drug Product Offered
11.4.3 Sandoz Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Sandoz Main Business Overview
11.4.5 Sandoz Latest Developments
11.5 Intas
11.5.1 Intas Company Information
11.5.2 Intas Neuromyelitis Optica Drug Product Offered
11.5.3 Intas Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Intas Main Business Overview
11.5.5 Intas Latest Developments
11.6 Gyjtrs
11.6.1 Gyjtrs Company Information
11.6.2 Gyjtrs Neuromyelitis Optica Drug Product Offered
11.6.3 Gyjtrs Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Gyjtrs Main Business Overview
11.6.5 Gyjtrs Latest Developments
11.7 NANG KUANG
11.7.1 NANG KUANG Company Information
11.7.2 NANG KUANG Neuromyelitis Optica Drug Product Offered
11.7.3 NANG KUANG Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 NANG KUANG Main Business Overview
11.7.5 NANG KUANG Latest Developments
11.8 Tianjin Kingyork
11.8.1 Tianjin Kingyork Company Information
11.8.2 Tianjin Kingyork Neuromyelitis Optica Drug Product Offered
11.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Tianjin Kingyork Main Business Overview
11.8.5 Tianjin Kingyork Latest Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Neuromyelitis Optica Drug Product Offered
11.9.3 Baxter Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Baxter Main Business Overview
11.9.5 Baxter Latest Developments
11.10 CSL
11.10.1 CSL Company Information
11.10.2 CSL Neuromyelitis Optica Drug Product Offered
11.10.3 CSL Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 CSL Main Business Overview
11.10.5 CSL Latest Developments
11. Grifols
11.11.1 Grifols Company Information
11.11.2 Grifols Neuromyelitis Optica Drug Product Offered
11.11.3 Grifols Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Grifols Main Business Overview
11.11.5 Grifols Latest Developments
11.12 Octapharma
11.12.1 Octapharma Company Information
11.12.2 Octapharma Neuromyelitis Optica Drug Product Offered
11.12.3 Octapharma Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Octapharma Main Business Overview
11.12.5 Octapharma Latest Developments
11.13 CBOP
11.13.1 CBOP Company Information
11.13.2 CBOP Neuromyelitis Optica Drug Product Offered
11.13.3 CBOP Neuromyelitis Optica Drug Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 CBOP Main Business Overview
11.13.5 CBOP Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Neuromyelitis Optica Drug Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Glucocorticoids
Table 3. Major Players of Immunotherapies
Table 4. Major Players of Others
Table 5. Neuromyelitis Optica Drug Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021)
Table 8. Neuromyelitis Optica Drug Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021)
Table 11. Global Neuromyelitis Optica Drug Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Neuromyelitis Optica Drug Revenue Market Share by Players (2019-2021E)
Table 13. Neuromyelitis Optica Drug Key Players Head office and Products Offered
Table 14. Neuromyelitis Optica Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neuromyelitis Optica Drug Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Neuromyelitis Optica Drug Market Size Market Share by Regions 2016-2021
Table 19. Americas Neuromyelitis Optica Drug Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Neuromyelitis Optica Drug Market Size Market Share by Country (2016-2021)
Table 21. Americas Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021)
Table 23. Americas Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021)
Table 25. APAC Neuromyelitis Optica Drug Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Neuromyelitis Optica Drug Market Size Market Share by Region (2016-2021)
Table 27. APAC Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021)
Table 29. APAC Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021)
Table 31. Europe Neuromyelitis Optica Drug Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Neuromyelitis Optica Drug Market Size Market Share by Country (2016-2021)
Table 33. Europe Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021)
Table 35. Europe Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Neuromyelitis Optica Drug Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Neuromyelitis Optica Drug Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Neuromyelitis Optica Drug Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Neuromyelitis Optica Drug
Table 44. Key Application and Potential Industries of Neuromyelitis Optica Drug
Table 45. Key Challenges of Neuromyelitis Optica Drug
Table 46. Key Trends of Neuromyelitis Optica Drug
Table 47. Global Neuromyelitis Optica Drug Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Neuromyelitis Optica Drug Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Neuromyelitis Optica Drug Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Neuromyelitis Optica Drug Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Neuromyelitis Optica Drug Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Neuromyelitis Optica Drug Market Size Market Share Forecast by Application (2021-2026)
Table 53. Pfizer Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 54. Pfizer Neuromyelitis Optica Drug Product Offered
Table 55. Pfizer Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Fresenius Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 59. Fresenius Neuromyelitis Optica Drug Product Offered
Table 60. Fresenius Main Business
Table 61. Fresenius Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Fresenius Latest Developments
Table 63. Teva Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 64. Teva Neuromyelitis Optica Drug Product Offered
Table 65. Teva Main Business
Table 66. Teva Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Teva Latest Developments
Table 68. Sandoz Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 69. Sandoz Neuromyelitis Optica Drug Product Offered
Table 70. Sandoz Main Business
Table 71. Sandoz Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Sandoz Latest Developments
Table 73. Intas Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 74. Intas Neuromyelitis Optica Drug Product Offered
Table 75. Intas Main Business
Table 76. Intas Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Intas Latest Developments
Table 78. Gyjtrs Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 79. Gyjtrs Neuromyelitis Optica Drug Product Offered
Table 80. Gyjtrs Main Business
Table 81. Gyjtrs Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Gyjtrs Latest Developments
Table 83. NANG KUANG Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 84. NANG KUANG Neuromyelitis Optica Drug Product Offered
Table 85. NANG KUANG Main Business
Table 86. NANG KUANG Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. NANG KUANG Latest Developments
Table 88. Tianjin Kingyork Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 89. Tianjin Kingyork Neuromyelitis Optica Drug Product Offered
Table 90. Tianjin Kingyork Main Business
Table 91. Tianjin Kingyork Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Tianjin Kingyork Latest Developments
Table 93. Baxter Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 94. Baxter Neuromyelitis Optica Drug Product Offered
Table 95. Baxter Main Business
Table 96. Baxter Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Baxter Latest Developments
Table 98. CSL Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 99. CSL Neuromyelitis Optica Drug Product Offered
Table 100. CSL Main Business
Table 101. CSL Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. CSL Latest Developments
Table 103. Grifols Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 104. Grifols Neuromyelitis Optica Drug Product Offered
Table 105. Grifols Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Grifols Main Business
Table 107. Grifols Latest Developments
Table 108. Octapharma Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 109. Octapharma Neuromyelitis Optica Drug Product Offered
Table 110. Octapharma Main Business
Table 111. Octapharma Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Octapharma Latest Developments
Table 113. CBOP Details, Company Type, Neuromyelitis Optica Drug Area Served and Its Competitors
Table 114. CBOP Neuromyelitis Optica Drug Product Offered
Table 115. CBOP Main Business
Table 116. CBOP Neuromyelitis Optica Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. CBOP Latest Developments
List of Figures
Figure 1. Neuromyelitis Optica Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuromyelitis Optica Drug Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Neuromyelitis Optica Drug Market Size Market Share by Type in 2020
Figure 7. Neuromyelitis Optica Drug in Acute Attack
Figure 8. Global Neuromyelitis Optica Drug Market: Acute Attack (2016-2021) & ($ Millions)
Figure 9. Neuromyelitis Optica Drug in Remission Prophylactic Treatment
Figure 10. Global Neuromyelitis Optica Drug Market: Remission Prophylactic Treatment (2016-2021) & ($ Millions)
Figure 11. Global Neuromyelitis Optica Drug Market Size Market Share by Application in 2020
Figure 12. Global Neuromyelitis Optica Drug Revenue Market Share by Player in 2020
Figure 13. Global Neuromyelitis Optica Drug Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Neuromyelitis Optica Drug Market Size 2016-2021 ($ Millions)
Figure 15. APAC Neuromyelitis Optica Drug Market Size 2016-2021 ($ Millions)
Figure 16. Europe Neuromyelitis Optica Drug Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Neuromyelitis Optica Drug Market Size 2016-2021 ($ Millions)
Figure 18. Americas Neuromyelitis Optica Drug Market Size Market Share by Country in 2020
Figure 19. Americas Neuromyelitis Optica Drug Market Size Market Share by Type in 2020
Figure 20. Americas Neuromyelitis Optica Drug Market Size Market Share by Application in 2020
Figure 21. United States Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Neuromyelitis Optica Drug Market Size Market Share by Regions in 2020
Figure 25. APAC Neuromyelitis Optica Drug Market Size Market Share by Type in 2020
Figure 26. APAC Neuromyelitis Optica Drug Market Size Market Share by Application in 2020
Figure 27. China Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Neuromyelitis Optica Drug Market Size Market Share by Country in 2020
Figure 34. Europe Neuromyelitis Optica Drug Market Size Market Share by Type in 2020
Figure 35. Europe Neuromyelitis Optica Drug Market Size Market Share by Application in 2020
Figure 36. Germany Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Neuromyelitis Optica Drug Market Size Market Share by Application in 2020
Figure 44. Egypt Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Neuromyelitis Optica Drug Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 50. APAC Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 51. Europe Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 53. United States Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 54. Canada Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 57. China Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 58. Japan Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 59. Korea Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 61. India Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 62. Australia Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 63. Germany Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 64. France Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 65. UK Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 66. Italy Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 67. Russia Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 68. Spain Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 71. Israel Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Neuromyelitis Optica Drug Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 시신경 척수염 약물 시장예측 2021년-2026년] (코드 : LPI-2201K02107) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 시신경 척수염 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 메니에르병 치료제 파이프 라인 시장예측 2021년-2026년
LPI-2201K02225 / LP Information / 2021년 12월 / 본 조사보고서는 메니에르병 치료제 파이프 라인의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Meniere Disease Drug Pipeline will have significant change from previous year. By the most conservative estimates of global Meniere Disease Drug Pipeline market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 펩타이드 기반 약물 시장예측 2021년-2026년
LPI-2201K02139 / LP Information / 2021년 12월 / 본 조사보고서는 펩타이드 기반 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Peptide-based Drug will have significant change from previous year. By the most conservative estimates of global Peptide-based Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 31480 million in 2020. Over...

세계의 전문 의약품 유통 시장예측 2021년-2026년
LPI-2201K02305 / LP Information / 2021년 12월 / 본 조사보고서는 전문 의약품 유통의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Specialty Drug Distribution will have significant change from previous year. By the most conservative estimates of global Specialty Drug Distribution market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 238470 million in...

세계의 치료제 모니터링 시장예측 2021년-2026년
LPI-2201K02314 / LP Information / 2021년 12월 / 본 조사보고서는 치료제 모니터링의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Therapeutic Drug Monitoring will have significant change from previous year. By the most conservative estimates of global Therapeutic Drug Monitoring market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1581.7 million in...